Want to see JP:7707 full AI Analyst Report?
Top Page
Precision System Science Co.,Ltd
(7707)
Select Model
Select Model
Rating:57Neutral
Price Target:
¥220.00
▲(18.28% Upside)
Action:Reiterated
Date:08/19/26
The score is mainly held back by weak and inconsistent cash-flow conversion despite the 2026 earnings rebound, which raises quality-of-earnings risk. Technicals are mildly positive with a modest uptrend and neutral momentum, while valuation (P/E ~15 and ~0.94% yield) is reasonable but not a strong catalyst.
Positive Factors
Recurring consumables revenue
Consumables and support revenue can create repeat business beyond one-time instrument sales. As the installed base expands, recurring purchases tied to testing activity may improve revenue visibility and strengthen customer retention.
Negative Factors
Weak cash conversion
The large gap between reported profit and operating cash flow raises quality-of-earnings risk. If working capital or investment continues to absorb cash, the company may need external funding even when its income statement appears profitable.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring consumables revenue
Consumables and support revenue can create repeat business beyond one-time instrument sales. As the installed base expands, recurring purchases tied to testing activity may improve revenue visibility and strengthen customer retention.
Read all positive factors
Precision System Science Co.,Ltd (7707) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.09B
Dividend Yield0.91%
Average Volume (3M)159.67K
Price to Earnings (P/E)15.1
Beta (1Y)0.87
Revenue Growth11.17%
EPS GrowthN/A
CountryJP
Employees151
SectorGeneral
Sector StrengthN/A
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)4.93
Shares Outstanding27,666,900
10 Day Avg. Volume171,040
30 Day Avg. Volume159,673
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.30
Price to Sales (P/S)1.02
P/FCF Ratio-105.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Precision System Science Co.,Ltd Business Overview & Revenue Model
Company Description
Precision System Science Co., Ltd. (PSS), along with its subsidiaries, specializes in the development, production, and global distribution of automated and physicochemical instruments, software, and various related goods, serving both the Japanese...
How the Company Makes Money
Precision System Science generates revenue primarily by selling laboratory/clinical automation instruments and the recurring consumables used with those instruments, plus related services. Key revenue streams typically include: (1) Instrument/syst...
Precision System Science Co.,Ltd Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
68
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.01B | 5.22B | 4.69B | 3.98B | 5.28B | 7.43B |
| Gross Profit | 1.51B | 1.58B | 1.38B | 950.38M | 1.35B | 2.49B |
| EBITDA | 295.81M | 409.05M | 10.06M | -661.75M | -594.05M | 740.33M |
| Net Income | 134.69M | 394.87M | -253.10M | -1.12B | -1.32B | 45.34M |
Balance Sheet | ||||||
| Total Assets | 5.57B | 5.85B | 4.94B | 6.40B | 9.76B | 11.41B |
| Cash, Cash Equivalents and Short-Term Investments | 942.70M | 1.37B | 1.04B | 1.92B | 2.45B | 2.76B |
| Total Debt | 885.01M | 1.03B | 564.21M | 1.37B | 3.88B | 4.03B |
| Total Liabilities | 1.68B | 1.76B | 1.18B | 2.25B | 4.54B | 4.90B |
| Stockholders Equity | 3.89B | 4.09B | 3.76B | 4.14B | 5.22B | 6.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -50.57M | 43.24M | -130.81M | -162.03M | -1.38B |
| Operating Cash Flow | 0.00 | 51.41M | 95.83M | -106.80M | -6.75M | 869.16M |
| Investing Cash Flow | 0.00 | -98.03M | -8.24M | 2.06B | -213.70M | -2.29B |
| Financing Cash Flow | 0.00 | 460.79M | -910.82M | -2.51B | -154.05M | 93.73M |
Precision System Science Co.,Ltd Technical Analysis
Positive
186.00
Price Trends
204.70
Positive
217.73
Positive
213.52
Positive
Market Momentum
3.86
Negative
56.23
Neutral
52.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7707, the sentiment is Positive. The current price of 186 is below the 20-day moving average (MA) of 212.90, below the 50-day MA of 204.70, and below the 200-day MA of 213.52, indicating a bullish trend. The MACD of 3.86 indicates Negative momentum. The RSI at 56.23 is Neutral, neither overbought nor oversold. The STOCH value of 52.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7707.
Precision System Science Co.,Ltd Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥9.79B | 27.52 | ― | ― | 13.46% | 42.41% | |
69 Neutral | ¥7.21B | 19.49 | ― | 4.57% | 9.39% | 44.42% | |
57 Neutral | ¥6.09B | 15.13 | ― | ― | 11.17% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | ¥15.05B | -32.46 | ― | ― | -18.71% | -246.54% | |
44 Neutral | ¥5.75B | -7.00 | ― | ― | 364.72% | 18.43% | |
42 Neutral | ¥9.23B | -7.98 | ― | ― | -56.16% | 3.12% |
* General Sector Average
JP:7707
Precision System Science Co.,Ltd
219.00
14.00
6.83%
JP:3386
Cosmo Bio Co., Ltd.
1,250.00
120.96
10.71%
JP:4570
Immuno-Biological Laboratories Co., Ltd.
1,088.00
611.05
128.11%
JP:4892
Cyfuse Biomedical K.K.
570.00
-52.00
-8.36%
JP:4978
ReproCELL Inc.
149.00
-29.00
-16.29%
JP:7776
CellSeed Inc.
231.00
-210.00
-47.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.